Page last updated: 2024-11-07

spironolactone and Enuresis

spironolactone has been researched along with Enuresis in 1 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Enuresis: Involuntary discharge of URINE after expected age of completed development of urinary control. This can happen during the daytime (DIURNAL ENURESIS) while one is awake or during sleep (NOCTURNAL ENURESIS). Enuresis can be in children or in adults (as persistent primary enuresis and secondary adult-onset enuresis).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chauvel, PJ1
Beveridge, J1
Stokes, GS1

Other Studies

1 other study available for spironolactone and Enuresis

ArticleYear
Increased plasma renin activity, secondary aldosteronism, and hypertension.
    American journal of diseases of children (1960), 1970, Volume: 119, Issue:2

    Topics: Child; Enuresis; Female; Humans; Hyperaldosteronism; Hypertension; Kidney Function Tests; Potassium;

1970